 | • レポートコード：MRC2-11QY06664 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はガレクチン3のグローバル市場について調査・分析したレポートです。種類別（GAL-300、GRMD-03、ANG-4021、KTI、その他）市場規模、用途別（肝硬変、門脈圧亢進症、転移性黒色腫、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ガレクチン3の競争状況、市場シェア ・世界のガレクチン3市場：種類別市場規模 2015年-2020年（GAL-300、GRMD-03、ANG-4021、KTI、その他） ・世界のガレクチン3市場：種類別市場規模予測 2021年-2026年（GAL-300、GRMD-03、ANG-4021、KTI、その他） ・世界のガレクチン3市場：用途別市場規模 2015年-2020年（肝硬変、門脈圧亢進症、転移性黒色腫、その他） ・世界のガレクチン3市場：用途別市場規模予測 2021年-2026年（肝硬変、門脈圧亢進症、転移性黒色腫、その他） ・北米のガレクチン3市場分析：米国、カナダ ・ヨーロッパのガレクチン3市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのガレクチン3市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のガレクチン3市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのガレクチン3市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Angion Biomedica Corp、Bristol-Myers Squibb Company、Galectin Therapeutics Inc、GlycoMimetics Inc、iTeos Therapeutics SA、MandalMed Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Galectin 3 Market
The global Galectin 3 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Galectin 3 Scope and Market Size
Galectin 3 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Galectin 3 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Galectin 3 market is segmented into
GAL-300
GRMD-03
ANG-4021
KTI
Others
Segment by Application, the Galectin 3 market is segmented into
Liver Cirrhosis
Portal Hypertension
Metastatic Melanoma
Others
Regional and Country-level Analysis
The Galectin 3 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Galectin 3 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Galectin 3 Market Share Analysis
Galectin 3 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Galectin 3 business, the date to enter into the Galectin 3 market, Galectin 3 product introduction, recent developments, etc.
The major vendors covered:
Angion Biomedica Corp
Bristol-Myers Squibb Company
Galectin Therapeutics Inc
GlycoMimetics Inc
iTeos Therapeutics SA
MandalMed Inc
…
1 Study Coverage
1.1 Galectin 3 Product Introduction
1.2 Market Segments
1.3 Key Galectin 3 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Galectin 3 Market Size Growth Rate by Type
1.4.2 GAL-300
1.4.3 GRMD-03
1.4.4 ANG-4021
1.4.5 KTI
1.4.6 Others
1.5 Market by Application
1.5.1 Global Galectin 3 Market Size Growth Rate by Application
1.5.2 Liver Cirrhosis
1.5.3 Portal Hypertension
1.5.4 Metastatic Melanoma
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Galectin 3 Market Size, Estimates and Forecasts
2.1.1 Global Galectin 3 Revenue 2015-2026
2.1.2 Global Galectin 3 Sales 2015-2026
2.2 Global Galectin 3, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Galectin 3 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Galectin 3 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Galectin 3 Competitor Landscape by Players
3.1 Galectin 3 Sales by Manufacturers
3.1.1 Galectin 3 Sales by Manufacturers (2015-2020)
3.1.2 Galectin 3 Sales Market Share by Manufacturers (2015-2020)
3.2 Galectin 3 Revenue by Manufacturers
3.2.1 Galectin 3 Revenue by Manufacturers (2015-2020)
3.2.2 Galectin 3 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Galectin 3 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Galectin 3 Revenue in 2019
3.2.5 Global Galectin 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Galectin 3 Price by Manufacturers
3.4 Galectin 3 Manufacturing Base Distribution, Product Types
3.4.1 Galectin 3 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Galectin 3 Product Type
3.4.3 Date of International Manufacturers Enter into Galectin 3 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Galectin 3 Market Size by Type (2015-2020)
4.1.1 Global Galectin 3 Sales by Type (2015-2020)
4.1.2 Global Galectin 3 Revenue by Type (2015-2020)
4.1.3 Galectin 3 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Galectin 3 Market Size Forecast by Type (2021-2026)
4.2.1 Global Galectin 3 Sales Forecast by Type (2021-2026)
4.2.2 Global Galectin 3 Revenue Forecast by Type (2021-2026)
4.2.3 Galectin 3 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Galectin 3 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Galectin 3 Market Size by Application (2015-2020)
5.1.1 Global Galectin 3 Sales by Application (2015-2020)
5.1.2 Global Galectin 3 Revenue by Application (2015-2020)
5.1.3 Galectin 3 Price by Application (2015-2020)
5.2 Galectin 3 Market Size Forecast by Application (2021-2026)
5.2.1 Global Galectin 3 Sales Forecast by Application (2021-2026)
5.2.2 Global Galectin 3 Revenue Forecast by Application (2021-2026)
5.2.3 Global Galectin 3 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Galectin 3 by Country
6.1.1 North America Galectin 3 Sales by Country
6.1.2 North America Galectin 3 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Galectin 3 Market Facts & Figures by Type
6.3 North America Galectin 3 Market Facts & Figures by Application
7 Europe
7.1 Europe Galectin 3 by Country
7.1.1 Europe Galectin 3 Sales by Country
7.1.2 Europe Galectin 3 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Galectin 3 Market Facts & Figures by Type
7.3 Europe Galectin 3 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Galectin 3 by Region
8.1.1 Asia Pacific Galectin 3 Sales by Region
8.1.2 Asia Pacific Galectin 3 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Galectin 3 Market Facts & Figures by Type
8.3 Asia Pacific Galectin 3 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Galectin 3 by Country
9.1.1 Latin America Galectin 3 Sales by Country
9.1.2 Latin America Galectin 3 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Galectin 3 Market Facts & Figures by Type
9.3 Central & South America Galectin 3 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Galectin 3 by Country
10.1.1 Middle East and Africa Galectin 3 Sales by Country
10.1.2 Middle East and Africa Galectin 3 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Galectin 3 Market Facts & Figures by Type
10.3 Middle East and Africa Galectin 3 Market Facts & Figures by Application
11 Company Profiles
11.1 Angion Biomedica Corp
11.1.1 Angion Biomedica Corp Corporation Information
11.1.2 Angion Biomedica Corp Description and Business Overview
11.1.3 Angion Biomedica Corp Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Angion Biomedica Corp Galectin 3 Products Offered
11.1.5 Angion Biomedica Corp Related Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Description and Business Overview
11.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Company Galectin 3 Products Offered
11.2.5 Bristol-Myers Squibb Company Related Developments
11.3 Galectin Therapeutics Inc
11.3.1 Galectin Therapeutics Inc Corporation Information
11.3.2 Galectin Therapeutics Inc Description and Business Overview
11.3.3 Galectin Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Galectin Therapeutics Inc Galectin 3 Products Offered
11.3.5 Galectin Therapeutics Inc Related Developments
11.4 GlycoMimetics Inc
11.4.1 GlycoMimetics Inc Corporation Information
11.4.2 GlycoMimetics Inc Description and Business Overview
11.4.3 GlycoMimetics Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlycoMimetics Inc Galectin 3 Products Offered
11.4.5 GlycoMimetics Inc Related Developments
11.5 iTeos Therapeutics SA
11.5.1 iTeos Therapeutics SA Corporation Information
11.5.2 iTeos Therapeutics SA Description and Business Overview
11.5.3 iTeos Therapeutics SA Sales, Revenue and Gross Margin (2015-2020)
11.5.4 iTeos Therapeutics SA Galectin 3 Products Offered
11.5.5 iTeos Therapeutics SA Related Developments
11.6 MandalMed Inc
11.6.1 MandalMed Inc Corporation Information
11.6.2 MandalMed Inc Description and Business Overview
11.6.3 MandalMed Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 MandalMed Inc Galectin 3 Products Offered
11.6.5 MandalMed Inc Related Developments
11.1 Angion Biomedica Corp
11.1.1 Angion Biomedica Corp Corporation Information
11.1.2 Angion Biomedica Corp Description and Business Overview
11.1.3 Angion Biomedica Corp Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Angion Biomedica Corp Galectin 3 Products Offered
11.1.5 Angion Biomedica Corp Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Galectin 3 Market Estimates and Projections by Region
12.1.1 Global Galectin 3 Sales Forecast by Regions 2021-2026
12.1.2 Global Galectin 3 Revenue Forecast by Regions 2021-2026
12.2 North America Galectin 3 Market Size Forecast (2021-2026)
12.2.1 North America: Galectin 3 Sales Forecast (2021-2026)
12.2.2 North America: Galectin 3 Revenue Forecast (2021-2026)
12.2.3 North America: Galectin 3 Market Size Forecast by Country (2021-2026)
12.3 Europe Galectin 3 Market Size Forecast (2021-2026)
12.3.1 Europe: Galectin 3 Sales Forecast (2021-2026)
12.3.2 Europe: Galectin 3 Revenue Forecast (2021-2026)
12.3.3 Europe: Galectin 3 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Galectin 3 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Galectin 3 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Galectin 3 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Galectin 3 Market Size Forecast by Region (2021-2026)
12.5 Latin America Galectin 3 Market Size Forecast (2021-2026)
12.5.1 Latin America: Galectin 3 Sales Forecast (2021-2026)
12.5.2 Latin America: Galectin 3 Revenue Forecast (2021-2026)
12.5.3 Latin America: Galectin 3 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Galectin 3 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Galectin 3 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Galectin 3 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Galectin 3 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Galectin 3 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Galectin 3 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Galectin 3 Market Segments
Table 2. Ranking of Global Top Galectin 3 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Galectin 3 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of GAL-300
Table 5. Major Manufacturers of GRMD-03
Table 6. Major Manufacturers of ANG-4021
Table 7. Major Manufacturers of KTI
Table 8. Major Manufacturers of Others
Table 9. Global Galectin 3 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Galectin 3 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Galectin 3 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Galectin 3 Sales Market Share by Regions (2015-2020)
Table 13. Global Galectin 3 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Galectin 3 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Galectin 3 Sales Share by Manufacturers (2015-2020)
Table 16. Global Galectin 3 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Galectin 3 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Galectin 3 as of 2019)
Table 18. Galectin 3 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Galectin 3 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Galectin 3 Price (2015-2020) (USD/Pcs)
Table 21. Galectin 3 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Galectin 3 Product Type
Table 23. Date of International Manufacturers Enter into Galectin 3 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Galectin 3 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Galectin 3 Sales Share by Type (2015-2020)
Table 27. Global Galectin 3 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Galectin 3 Revenue Share by Type (2015-2020)
Table 29. Galectin 3 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Galectin 3 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Galectin 3 Sales Share by Application (2015-2020)
Table 32. North America Galectin 3 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Galectin 3 Sales Market Share by Country (2015-2020)
Table 34. North America Galectin 3 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Galectin 3 Revenue Market Share by Country (2015-2020)
Table 36. North America Galectin 3 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Galectin 3 Sales Market Share by Type (2015-2020)
Table 38. North America Galectin 3 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Galectin 3 Sales Market Share by Application (2015-2020)
Table 40. Europe Galectin 3 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Galectin 3 Sales Market Share by Country (2015-2020)
Table 42. Europe Galectin 3 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Galectin 3 Revenue Market Share by Country (2015-2020)
Table 44. Europe Galectin 3 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Galectin 3 Sales Market Share by Type (2015-2020)
Table 46. Europe Galectin 3 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Galectin 3 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Galectin 3 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Galectin 3 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Galectin 3 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Galectin 3 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Galectin 3 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Galectin 3 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Galectin 3 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Galectin 3 Sales Market Share by Application (2015-2020)
Table 56. Latin America Galectin 3 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Galectin 3 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Galectin 3 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Galectin 3 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Galectin 3 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Galectin 3 Sales Market Share by Type (2015-2020)
Table 62. Latin America Galectin 3 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Galectin 3 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Galectin 3 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Galectin 3 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Galectin 3 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Galectin 3 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Galectin 3 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Galectin 3 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Galectin 3 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Galectin 3 Sales Market Share by Application (2015-2020)
Table 72. Angion Biomedica Corp Corporation Information
Table 73. Angion Biomedica Corp Description and Major Businesses
Table 74. Angion Biomedica Corp Galectin 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Angion Biomedica Corp Product
Table 76. Angion Biomedica Corp Recent Development
Table 77. Bristol-Myers Squibb Company Corporation Information
Table 78. Bristol-Myers Squibb Company Description and Major Businesses
Table 79. Bristol-Myers Squibb Company Galectin 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bristol-Myers Squibb Company Product
Table 81. Bristol-Myers Squibb Company Recent Development
Table 82. Galectin Therapeutics Inc Corporation Information
Table 83. Galectin Therapeutics Inc Description and Major Businesses
Table 84. Galectin Therapeutics Inc Galectin 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Galectin Therapeutics Inc Product
Table 86. Galectin Therapeutics Inc Recent Development
Table 87. GlycoMimetics Inc Corporation Information
Table 88. GlycoMimetics Inc Description and Major Businesses
Table 89. GlycoMimetics Inc Galectin 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. GlycoMimetics Inc Product
Table 91. GlycoMimetics Inc Recent Development
Table 92. iTeos Therapeutics SA Corporation Information
Table 93. iTeos Therapeutics SA Description and Major Businesses
Table 94. iTeos Therapeutics SA Galectin 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. iTeos Therapeutics SA Product
Table 96. iTeos Therapeutics SA Recent Development
Table 97. MandalMed Inc Corporation Information
Table 98. MandalMed Inc Description and Major Businesses
Table 99. MandalMed Inc Galectin 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. MandalMed Inc Product
Table 101. MandalMed Inc Recent Development
Table 102. Global Galectin 3 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 103. Global Galectin 3 Sales Market Share Forecast by Regions (2021-2026)
Table 104. Global Galectin 3 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 105. Global Galectin 3 Revenue Market Share Forecast by Regions (2021-2026)
Table 106. North America: Galectin 3 Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. North America: Galectin 3 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Europe: Galectin 3 Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Europe: Galectin 3 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Asia Pacific: Galectin 3 Sales Forecast by Region (2021-2026) (K Pcs)
Table 111. Asia Pacific: Galectin 3 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 112. Latin America: Galectin 3 Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Latin America: Galectin 3 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Middle East and Africa: Galectin 3 Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Middle East and Africa: Galectin 3 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 117. Key Challenges
Table 118. Market Risks
Table 119. Main Points Interviewed from Key Galectin 3 Players
Table 120. Galectin 3 Customers List
Table 121. Galectin 3 Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Galectin 3 Product Picture
Figure 2. Global Galectin 3 Sales Market Share by Type in 2020 & 2026
Figure 3. GAL-300 Product Picture
Figure 4. GRMD-03 Product Picture
Figure 5. ANG-4021 Product Picture
Figure 6. KTI Product Picture
Figure 7. Others Product Picture
Figure 8. Global Galectin 3 Sales Market Share by Application in 2020 & 2026
Figure 9. Liver Cirrhosis
Figure 10. Portal Hypertension
Figure 11. Metastatic Melanoma
Figure 12. Others
Figure 13. Galectin 3 Report Years Considered
Figure 14. Global Galectin 3 Market Size 2015-2026 (US$ Million)
Figure 15. Global Galectin 3 Sales 2015-2026 (K Pcs)
Figure 16. Global Galectin 3 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Galectin 3 Sales Market Share by Region (2015-2020)
Figure 18. Global Galectin 3 Sales Market Share by Region in 2019
Figure 19. Global Galectin 3 Revenue Market Share by Region (2015-2020)
Figure 20. Global Galectin 3 Revenue Market Share by Region in 2019
Figure 21. Global Galectin 3 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Galectin 3 Revenue in 2019
Figure 23. Galectin 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Galectin 3 Sales Market Share by Type (2015-2020)
Figure 25. Global Galectin 3 Sales Market Share by Type in 2019
Figure 26. Global Galectin 3 Revenue Market Share by Type (2015-2020)
Figure 27. Global Galectin 3 Revenue Market Share by Type in 2019
Figure 28. Global Galectin 3 Market Share by Price Range (2015-2020)
Figure 29. Global Galectin 3 Sales Market Share by Application (2015-2020)
Figure 30. Global Galectin 3 Sales Market Share by Application in 2019
Figure 31. Global Galectin 3 Revenue Market Share by Application (2015-2020)
Figure 32. Global Galectin 3 Revenue Market Share by Application in 2019
Figure 33. North America Galectin 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Galectin 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Galectin 3 Sales Market Share by Country in 2019
Figure 36. North America Galectin 3 Revenue Market Share by Country in 2019
Figure 37. U.S. Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Galectin 3 Market Share by Type in 2019
Figure 42. North America Galectin 3 Market Share by Application in 2019
Figure 43. Europe Galectin 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Galectin 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Galectin 3 Sales Market Share by Country in 2019
Figure 46. Europe Galectin 3 Revenue Market Share by Country in 2019
Figure 47. Germany Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Galectin 3 Market Share by Type in 2019
Figure 58. Europe Galectin 3 Market Share by Application in 2019
Figure 59. Asia Pacific Galectin 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Galectin 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Galectin 3 Sales Market Share by Region in 2019
Figure 62. Asia Pacific Galectin 3 Revenue Market Share by Region in 2019
Figure 63. China Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Galectin 3 Market Share by Type in 2019
Figure 86. Asia Pacific Galectin 3 Market Share by Application in 2019
Figure 87. Latin America Galectin 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Galectin 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Galectin 3 Sales Market Share by Country in 2019
Figure 90. Latin America Galectin 3 Revenue Market Share by Country in 2019
Figure 91. Mexico Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Galectin 3 Market Share by Type in 2019
Figure 98. Latin America Galectin 3 Market Share by Application in 2019
Figure 99. Middle East and Africa Galectin 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Galectin 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Galectin 3 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Galectin 3 Revenue Market Share by Country in 2019
Figure 103. Turkey Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Galectin 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Galectin 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Galectin 3 Market Share by Type in 2019
Figure 110. Middle East and Africa Galectin 3 Market Share by Application in 2019
Figure 111. North America Galectin 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Galectin 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Galectin 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Galectin 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Galectin 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Galectin 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Galectin 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Galectin 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Galectin 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Galectin 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
尋常性乾癬治療の世界市場（～2026年） Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy. When treating plaque psoriasis, it must be remembered that topical medications and light will have difficulty penetrating through th…- 肝硬変の世界市場（～2026年） Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. Alcohol has been identified as the strongest risk factor for liver cirrhosis. Market Analysis and Insights: Global Liver Cirrhosis Market The global Liver Cirrhosis …
- 転移性ブドウ膜黒色腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Metastatic Uveal Melanoma Thereapeutics Market The global Metastatic Uveal Melanoma Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metastatic Uveal Melanoma Thereapeu…
- 肝硬変治療薬の世界市場（～2026年） Market Analysis and Insights: Global Liver Cirrhosis Therapeutics Market The global Liver Cirrhosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Liver Cirrhosis Therapeutics Scope and Market Size Liver …
- 転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…